DATAPHARM A/S: Financial statements 2022
CVR: 72323211
DATAPHARM A/S (CVR 72323211) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK 840,867 compared with DKK 602,055 the year before. Equity amounted to DKK 9,738,537. The solvency ratio was 88.8%.
- Profit/Loss
- 840,867 kr.
- Equity
- 9,738,537 kr.
- Total Assets
- 10,971,539 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | 841 t. | 9.7 mio. | 0 |
| 2021 | - | - | 602 t. | 8.9 mio. | 0 |
| 2020 | - | - | 305 t. | 8.3 mio. | 0 |
| 2019 | - | - | -2.6 mio. | 8 mio. | - |
| 2018 | - | - | -2.5 mio. | 10.5 mio. | - |
Keep an eye on DATAPHARM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 15, 2022, Dorte Kamp Teglgård has joined the board of directors of DATAPHARM A/S.
As of December 15, 2022, Tue Askaa has left the board of directors of DATAPHARM A/S.
As of August 22, 2022, Jakob Bjørnholt Tjelum has joined the board of directors of DATAPHARM A/S.
DATAPHARM A/S has published its annual report for 2021. The net result was DKK 602,055.
About DATAPHARM A/S
DATAPHARM A/S is a Danish company of the type Aktieselskab based in København K, founded in 1983. The company is registered under the industry Computerprogrammering. The management consists of Henrik Bruun. The company is owned by D.A. INVEST OG UDVIKLING A/S. The company has 4 employees. In 2025, the company reported a net result of DKK 657,407 compared with DKK 650,613 the year before. Equity amounted to DKK 11,750,274.
